Hemorrhoids Epidemiology Forecast

DelveInsight's ' Hemorrhoids - Epidemiology Forecast to 2030' report delivers an in-depth understanding of the disease, historical and forecasted Hemorrhoids epidemiology in the 7MM, i.e., the United States, EU5 (Germany, Spain, Italy, France, and the United Kingdom), and Japan.


Geographies Covered

  • The United States
  • EU5 (Germany, France, Italy, Spain, and the United Kingdom)
  • Japan


Study Period: 2017-2030


Hemorrhoids Understanding

The DelveInsight Hemorrhoids epidemiology report gives a thorough understanding of the Hemorrhoids by including details such as disease definition, symptoms, causes, pathophysiology, and diagnosis. It also provides treatment algorithms and treatment guidelines for Hemorrhoids in the US, Europe, and Japan. The report covers the detailed information of the Hemorrhoids epidemiology scenario in seven major countries (US, EU5, and Japan).


Hemorrhoids Epidemiology Perspective by DelveInsight

The Hemorrhoids epidemiology division provides insights about historical and current patient pool and forecasted trend for every seven major countries. The Hemorrhoids epidemiology data are studied through all possible division to give a better understanding of the Disease scenario in 7MM. The Hemorrhoids epidemiology segment covers the epidemiology data in the US, EU5 countries (Germany, Spain, Italy, France, and the UK), and Japan from 2017 to 2030. It also helps to recognize the causes of current and forecasted trends by exploring numerous studies, survey reports and views of key opinion leaders.


Hemorrhoids Detailed Epidemiology Segmentation

The Hemorrhoids epidemiology covered in the report provides historical as well as forecasted Hemorrhoids epidemiology scenario in the 7MM covering the United States, EU5 countries (Germany, Spain, Italy, France, and the United Kingdom) and Japan from 2017 to 2030.

The DelveInsight Hemorrhoids report also provides the epidemiology trends observed in the 7MM during the study period, along with the assumptions undertaken. The calculated data are presented with relevant tables and graphs to give a clear view of the epidemiology at first sight.


Scope of the Report

  • The Hemorrhoids report covers a detailed overview explaining its causes, symptoms, classification, pathophysiology, diagnosis and treatment patterns
  • The Hemorrhoids Epidemiology Report and Model provide an overview of the risk factors and global trends of Hemorrhoids in the seven major markets (7MM:US, France, Germany, Italy, Spain, UK, and Japan)
  • The report provides insight about the historical and forecasted patient pool of Hemorrhoids in seven major markets covering the United States, EU5 (Germany, Spain, France, Italy, UK), and Japan
  • The report helps to recognize the growth opportunities in the 7MM with respect to the patient population
  • The report assesses the disease risk and burden and highlights the unmet needs of Hemorrhoids
  • The report provides the segmentation of the Hemorrhoids epidemiology


Report Highlights

  • 11-Year Forecast of Hemorrhoids epidemiology
  • 7MM Coverage
  • Total Cases of Hemorrhoids
  • Total Cases of Hemorrhoids according to segmentation
  • Diagnosed cases of Hemorrhoids


KOL- Views

We interview, KOLs and SME's opinion through primary research to fill the data gaps and validate our secondary research. The opinion helps to understand the total patient population and current treatment pattern. This will support the clients in potential upcoming novel treatment by identifying the overall scenario of the indications.


Key Questions Answered

  • What will be the growth opportunities in the 7MM with respect to the patient population pertaining to Hemorrhoids?
  • What are the key findings pertaining to the Hemorrhoids epidemiology across 7MM and which country will have the highest number of patients during the forecast period (2017-2030)?
  • What would be the total number of patients of Hemorrhoids across the 7MM during the forecast period (2017-2030)?
  •  Among the EU5 countries, which country will have the highest number of patients during the forecast period (2017-2030)?
  • At what CAGR the patient population is expected to grow in 7MM during the forecast period (2017-2030)?
  • What is the disease risk, burden and unmet needs of the Hemorrhoids?
  • What are the currently available treatments of Hemorrhoids?


Reasons to buy

  • The Hemorrhoids Epidemiology report will allow the user to -
  • Develop business strategies by understanding the trends shaping and driving the global Hemorrhoids market
  • Quantify patient populations in the global Hemorrhoids market to improve product design, pricing, and launch plans
  • Organize sales and marketing efforts by identifying the age groups and sex that present the best opportunities for Hemorrhoids therapeutics in each of the markets covered
  • Understand the magnitude of Hemorrhoids population by its epidemiology
  • The Hemorrhoids Epidemiology Model developed by DelveInsight is easy to navigate, interactive with dashboards, and epidemiology based with transparent and consistent methodologies. Moreover, the model supports data presented in the report and showcases disease trends over 11-year forecast period using reputable sources


Key Assessments

  • Patient Segmentation
  • Disease Risk and Burden
  • Risk of disease by the segmentation
  • Factors driving growth in a specific patient population

1. Key Insights 

2. Executive Summary of Hemorrhoids

3.  Hemorrhoids: Disease Background and Overview

3.1. Introduction

3.2. Sign and Symptoms

3.3. Pathophysiology

3.4. Risk Factors

3.5. Diagnosis

4. Patient Journey

5. Epidemiology and Patient Population

5.1. Epidemiology Key Findings

5.2. Assumptions and Rationale: 7MM

5.3. Epidemiology Scenario: 7MM

5.3.1.  Hemorrhoids Epidemiology Scenario in the 7MM (2017- 2030)

5.4. United States Epidemiology

5.4.1.  Hemorrhoids Epidemiology Scenario in the United States (2017- 2030)

5.5. EU-5 Country-wise Epidemiology

5.5.1. Germany Epidemiology

5.5.1.1.  Hemorrhoids Epidemiology Scenario in Germany (2017- 2030)

5.5.2. France Epidemiology

5.5.2.1.  Hemorrhoids Epidemiology Scenario in France (2017- 2030)

5.5.3. Italy Epidemiology

5.5.3.1.  Hemorrhoids Epidemiology Scenario in Italy (2017- 2030)

5.5.4. Spain Epidemiology

5.5.4.1.  Hemorrhoids Epidemiology Scenario in Spain (2017- 2030)

5.5.5. United Kingdom Epidemiology

5.5.5.1.  Hemorrhoids Epidemiology Scenario in the United Kingdom (2017-2030)

5.6. Japan Epidemiology

5.6.1.  Hemorrhoids Epidemiology Scenario in Japan (2017- 2030)

6. Treatment Algorithm, Current Treatment, and Medical Practices

6.1.  Hemorrhoids Treatment and Management

6.2.  Hemorrhoids Treatment Algorithm

7. KOL Views

8. Unmet Needs

9.  Appendix

9.1. Bibliography

9.2. Report Methodology

10. DelveInsight Capabilities

11. Disclaimer

12. About DelveInsight

*The table of contents is not exhaustive; will be provided in the final report

Table 1   Hemorrhoids Epidemiology in 7MM (2017-2030)

Table 2  Hemorrhoids Diagnosed and Treatable Cases in 7MM (2017-2030)

Table 3  Hemorrhoids Epidemiology in the United States (2017-2030)

Table 4  Hemorrhoids Diagnosed and Treatable Cases in the United States (2017-2030)

Table 5  Hemorrhoids Epidemiology in Germany (2017-2030)

Table 6  Hemorrhoids Diagnosed and Treatable Cases in Germany (2017-2030)

Table 7  Hemorrhoids Epidemiology in France (2017-2030)

Table 8  Hemorrhoids Diagnosed and Treatable Cases in France (2017-2030)

Table 9  Hemorrhoids Epidemiology in Italy (2017-2030)

Table 10 Hemorrhoids Diagnosed and Treatable Cases in Italy (2017-2030)

Table 11 Hemorrhoids Epidemiology in Spain (2017-2030)

Table 12 Hemorrhoids Diagnosed and Treatable Cases in Spain (2017-2030)

Table 13 Hemorrhoids Epidemiology in the United Kingdom (2017-2030)

Table 14 Hemorrhoids Diagnosed and Treatable Cases in the United Kingdom (2017-2030)

Table 15 Hemorrhoids Epidemiology in Japan (2017-2030)

Table 16 Hemorrhoids Diagnosed and Treatable Cases in Japan (2017-2030)

Figure 1  Hemorrhoids Epidemiology in 7MM (2017-2030)

Figure 2  Hemorrhoids Diagnosed and Treatable Cases in 7MM (2017-2030)

Figure 3  Hemorrhoids Epidemiology in the United States (2017-2030)

Figure 4  Hemorrhoids Diagnosed and Treatable Cases in the United States (2017-2030)

Figure 5  Hemorrhoids Epidemiology in Germany (2017-2030)

Figure 6  Hemorrhoids Diagnosed and Treatable Cases in Germany (2017-2030)

Figure 7  Hemorrhoids Epidemiology in France (2017-2030)

Figure 8  Hemorrhoids Diagnosed and Treatable Cases in France (2017-2030)

Figure 9  Hemorrhoids Epidemiology in Italy (2017-2030)

Figure 10 Hemorrhoids Diagnosed and Treatable Cases in Italy (2017-2030)

Figure 11 Hemorrhoids Epidemiology in Spain (2017-2030)

Figure 12 Hemorrhoids Diagnosed and Treatable Cases in Spain (2017-2030)

Figure 13 Hemorrhoids Epidemiology in the United Kingdom (2017-2030)

Figure 14 Hemorrhoids Diagnosed and Treatable Cases in the United Kingdom (2017-2030)

Figure 15 Hemorrhoids Epidemiology in Japan (2017-2030)

Figure 16 Hemorrhoids Diagnosed and Treatable Cases in Japan (2017-2030)

*The table of contents is not exhaustive; will be provided in the final report



  • Tags:
  • Hemorrhoids Epidemiology
  • Hemorrhoids
  • Hemorrhoids Pipeline
  • Hemorrhoids Companies
  • Hemorrhoids prevalent population
  • Hemorrhoids incident population
  • Hemorrhoids patients diagnosed
  • Hemorrhoids treatment algorithm

Forward to Friend

Need A Quote